Physician profile
Amy Lyn Gallagher
NPI 1740433572
$1,669.82
in general payments reported to CMS, 2019-2025
11 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $295 · 2022: $760 · 2023: $219 · 2024: $217 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $801.30 | 2021-2025 | Spinemask, Cascadia Interbody System, Capri Corpectomy Cage System |
| Si-Bone, INC. | $593.99 | 2022-2023 | |
| Orthofix Medical, INC. | $53.40 | 2024 | Spinal-Stim, Cervical-Stim |
| Cerapedics INC. | $45.09 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Novocure INC. | $39.54 | 2023 | Optune |
| Globus Medical, INC. | $36.54 | 2022 | |
| Medtronic, INC. | $22.79 | 2021 | |
| Integra Lifesciences Corporation | $22.59 | 2022 | |
| Novo Nordisk INC | $18.97 | 2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $17.95 | 2023 | Andexxa |
| Takeda Pharmaceuticals U.S.A., INC. | $17.66 | 2025 | Eohilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.